Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Modeling disease in human embryonic stem cells using new genetic tools

  • Post author:
  • Post published:November 3, 2025
  • Post category:

The use of stem cells or stem cell-derived cells to treat disease is one important goal of stem cell research. A second, important use for stem cells is the creation…

Continue ReadingModeling disease in human embryonic stem cells using new genetic tools

Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State

  • Post author:
  • Post published:November 3, 2025
  • Post category:

A subset of intellectual disability cases in humans are caused by mutations in an X-linked gene essential for a quality control mechanism called nonsense-mediated RNA decay (NMD). Patients with mutations…

Continue ReadingRole of the NMD RNA Decay Pathway in Maintaining the Stem-Like State

Modeling Alexander disease using patient-specific induced pluripotent stem cells

  • Post author:
  • Post published:November 3, 2025
  • Post category:

Alexander disease (AxD) is a devastating childhood disease that affects neural development and causes mental retardation, seizures and spasticity. The most common form of AxD occurs during the first two…

Continue ReadingModeling Alexander disease using patient-specific induced pluripotent stem cells

Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons

  • Post author:
  • Post published:November 3, 2025
  • Post category:

A major medical problem in CA is the growing population of individuals with neurodegenerative diseases, including Parkinson’s (PD) and Huntington’s (HD) disease. These diseases affect millions of people, sometimes during…

Continue ReadingCommon molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons

Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain

  • Post author:
  • Post published:November 3, 2025
  • Post category:

White matter is the infrastructure of the brain, providing conduits for communication between neural regions. White matter continues to mature from birth until early adulthood, particularly in regions of brain…

Continue ReadingStem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain

Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration

  • Post author:
  • Post published:November 3, 2025
  • Post category:

Amyotrophic lateral sclerosis (ALS) is an idiopathic adult-onset degenerative disease characterized by progressive weakness from loss of upper and lower motor neurons. Onset is insidious, progression is essentially linear, and…

Continue ReadingStem cell models to analyze the role of mutated C9ORF72 in neurodegeneration

The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

  • Post author:
  • Post published:November 3, 2025
  • Post category:

Continue ReadingThe HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

Progenitor Cells Secreting GDNF for the Treatment of ALS

  • Post author:
  • Post published:November 3, 2025
  • Post category:

This project aims to use a powerful combined neural progenitor cell and growth factor approach to treat patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig’s Disease). ALS is a…

Continue ReadingProgenitor Cells Secreting GDNF for the Treatment of ALS

Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy

  • Post author:
  • Post published:November 3, 2025
  • Post category:

Alzheimer’s disease (AD), the leading cause of dementia, results in profound loss of memory and cognitive function, and ultimately death. In the US, someone develops AD every 69 seconds and…

Continue ReadingRestoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy

MSC engineered to produce BDNF for the treatment of Huntington’s disease

  • Post author:
  • Post published:November 3, 2025
  • Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease
  • Go to the previous page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 34
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us